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S. Franks,* G. Lloyd, G. Fishwick, M. Bown and R. SayersCardiovascular Sciences Department, University of Leicester, Clinical Sciences Building, Leicester, UKObjective. To report the experience of endovascular repair (ER) in patients with ruptured and symptomatic abdominal
aortic aneurysms (rAAA and sAAA), comparing results with a cohort of controls who underwent open repair (OR) of sAAA
or rAAA.
Design. A historically controlled cohort study.
Materials. Retrospective data from 21 patients who underwent ER and prospective data from 23 patients who underwent
OR.
Methods. Results were compared using the Mann–Whitney U-test.
Results. Eleven ER patients had sAAAs and 10 had rAAAs. Nine OR patients had rAAAs and 13 had sAAAs. Thirty-day
mortality was 11% in patients with rAAA in the ER group, and 54% in the OR group (pZ0.03). There were no post-
operative deaths in the patients who had an sAAA in the ER group, and one death in the patients who had sAAA in the OR
group. Results as expressed as mean ER value versus mean OR value and p-value. ER was associated with significant
reductions in the length of operation (2.6 versus 3.1 h, pZ0.03), blood transfusion requirements (0.86 versus 10.7 units
p!0.01), time in critical care (1.5 versus 6.1 days, pZ0.02), and total hospital stay (8.5 versus 17.5 days, pZ0.01)
compared with OR. There was no difference in time from admission to arrival in theatre between the two groups (3.4 versus
5.0 h, pZ0.35).
Conclusions. In patients with rAAA and sAAA that are suitable for stenting, ER has reduced mortality compared with
open repair. Assessment for ER does not cause a pre-operative delay, operating time is reduced, blood transfusion
requirements are reduced and there is a faster recovery.Keywords: Abdominal aortic aneurysm; Ruptured aneurysm; Symptomatic aneurysm; Endovascular repair.Introduction
Ruptured abdominal aortic aneurysm (rAAA) causes
7500 deaths per annum in England and Wales,1 and
UK Department of Health figures from 1979 to 19982
show that the combined community and in hospital
mortality for this condition is increasing, having risen
from 0.05 deaths per 1000 population per annum, to
0.08 deaths per 1000 in 19 years.
The surgical treatment for rAAA has remained
largely unchanged for the last 40 years. During this
time, despite advances in critical care medicine, the
mortality rate associated with surgery has changed
little, with a recent meta-analysis by Bown et al.3
estimating the mortality rate in patients who reach
hospital alive as 48% over the last 40 years. Multiorganing author. S. Franks, Cardiovascular Sciences Depart-
sity of Leicester, Clinical Sciences Building, Leicester,
: sarahcfranks@btinternet.com
0345+ 06 $35.00/0 q 2005 Elsevier Ltd. All rights reserfailure is a significant cause of mortality in those
patients who survive surgery,4 a complication that can
be the result of hypovolaemia, consumptive coagulo-
pathy, hypothermia and acidosis. In addition, some
patients present with symptomatic but non-ruptured
AAA and undergo urgent surgery as soon as
possible—often on the next available operating list.
The cause of symptoms (abdominal or back pain and
AAA tenderness) is unknown but may be due to
stretching of the sac and a sign of impending rupture.
These patients often do not have a full pre-operative
work-up (when compared to elective cases) and the
mortality is higher than the elective situation—often in
the region of 16%.4
ER was first described in the literature by Parodi in
1991,5 and is a minimally invasive alternative
approach that results in less disturbance of the
patient’s homeostatic mechanisms, and may improve
morbidity and mortality rates. While ER undergoes
evaluation for the elective treatment of AAAs by theEur J Vasc Endovasc Surg 31, 345–350 (2006)
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an endovascular programme is already established)
are now using ER to treat patients with rAAA. Since,
the first case report of ER for a rAAAwas published in
1994,7 several feasibility studies have been reported,
which assess suitability of rAAA patients for ER. The
results of these studies show that between 28 and 80%
of rAAA patients are suitable for ER.8–10 Several
centres10–16 have reported on case series of between
12 and 21 patients, with mortality rates ranging from
9.5 to 45%. This paper reviews our experience of ER for
ruptured and symptomatic abdominal aortic
aneurysms.Methods
Examination of the Department of Vascular Surgery
database identified 22 patients with ruptured or
symptomatic AAA who had undergone urgent or
emergency ER at Leicester Royal Infirmary (LRI) from
July 1996 to April 2003. These hospital records were
retrieved—apart from one set of notes, which were
lost. This patient was excluded from the study.
Data pertaining to pre-operative management,
physiological and operative severity score for the
enumeration of mortality and morbidity (POSSUM)
scores, intra-operative course, and post-operative
morbidity, mortality and hospital stay was collected.
For a patient to be selected for emergency endovas-
cular surgery, three criteria had to be met. The patient
had to be haemodynamically stable enough to have
undergone a CT scan. We scan the majority patients
with a suspected rAAA, but those who are in extremis
are transferred directly to theatre, and hence were
excluded from the study. Once scanned, the aneurysm
must be morphologically suitable for ER. Finally, the
correct personnel had to be available on the day to
perform the surgery. In our department all endovas-
cular repairs take the form of a joint procedure
between the surgical and radiological departments.
There was no fixed protocol for fluid resuscitation
but the vascular department have liaised closely with
colleagues in the accident and emergency department
who appreciate the need for rapid transfer for CT. In
addition, aggressive fluid resuscitation was avoided
(to prevent further bleeding) and patients who were
conscious and able to talk were given maintenance
fluids only, despite hypotension.
A fixed spiral CT protocol including a plain scan of
the abdomen and pelvis with 10 mm slices, followed
by the administration of 100 ml of intravenous contrast
at 3 ml/s, and the acquisition of 3 mm slices from
above the renal arteries to below the iliac bifurcation inEur J Vasc Endovasc Surg Vol 31, April 2006the arterial phase (Phillips Sura, Philips Medical
System, Best, The Netherlands) was used. An initial
assessment of suitability for ER was made from the
axial images, and if the patient was suitable (based on
proximal neck anatomy) they were transferred to
theatre immediately and the procedure commenced.
Meanwhile, 2D angiographic reconstructions were
prepared, and detailed length and diameter measure-
ments made on a workstation in the radiology
department. Hard copies of the scans were then
brought to theatre by the radiologist who chose the
best device according to the measurements made, and
then joined the procedure.
Patients are deemed suitable for ER according to
the combination of neck length, neck angulation and
iliac diameter. In emergency cases, we accepted a
minimum neck length of 10 mm, if it is straight, but
an angulated neck necessitates 15–20 mm of length.
We have treated patients with up to 908 of angulation,
although the devices are not licensed for use in such
aneurysms. The diameter of external iliac arteries
(EIA) necessary for successful graft insertion varies
according to the size of the neck (and consequently
the size of the packaged device). AAAs with smaller
necks can be treated through EIAs of 5.5–6 mm in
diameter, but as neck diameter increases so must EIA
diameter. As a general rule stents are oversized by
10–15% of the neck diameter to ensure a tight fit at the
top end.
A supply of devices of different sizes together with
differing body and limb lengths were kept in theatres
ready to use, on sale or return basis. Excluder
bifurcated grafts (WL Gore and Associates Inc.,
Delaware, USA) with top end diameters from 23 to
32 mm, and limb extensions with diameters ranging
from 12 to 14.5 mm are available. Cook (Cook Group
Inc., Bloomington, USA) supply us with bifurcated
stents with proximal end diameters ranging from 26
to 32 mm, and limb diameters ranging from 12 to
24 mm. We also have Talent mono-iliac stents
(Medtronic Inc., Minneapolis, USA), with top end
diameters from 24 to 36 mm and limb diameters from
12 to 24 mm. This variety enables us to treat most
AAAs despite individual variation in aorto-iliac
anatomy.17
Both aorto-mono-iliac and bifurcated devices were
used in this case series, according to the preference of
the radiologist who chose the device. Three stent-graft
devices were used—the Talent stent-graft, the
Excluder device, and the Zenith device, which all
have low endoleak rates.18 In general, we prefer the
Excluder device for small caliber iliac arteries, the
Zenith device in short proximal necks and the Talent
for large diameter proximal necks. The Cook device
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both proximally and distally before full deployment.
Cases were performed under either local anaes-
thetic with sedation, epidural or general anaesthesia as
determined by the anaesthetists involved in each case.
Cardiovascular monitoring was performed with peri-
pheral and/or central intravenous access; and a
urinary catheter, arterial line and oxygen saturation
probe (pulse oximetry) were in situ.
If the patient became haemodynamically unstable
during the procedure, a variety of techniques to
achieve aortic occlusion were used. Partial deploy-
ment of some types of device (Zenith or Talent) can
achieve a degree of aortic occlusion and some second-
generation devices (Talent) had a balloon incorporated
into the device, which could be inflated to occlude the
aorta. Alternatively, we occasionally use an occlusion
balloon (Boston Scientific, Natick, USA) or a moulding
balloon (Cook), inserted into the aorta via the groin
arteries, supported by a 16F long (35 cm) sheath (St
Jude Medical, St Paul, USA), to prevent blood loss
from the aorta.
Results were compared to prospectively gathered
data on a group of 22 historical controls who under-
went open aneurysm repair (OR) for rAAA and sAAA
from December 2000 to July 2001. These patients had
undergone endoaneurysmorraphy using either
straight of bifurcated grafts and either an abdominal
or retroperitoneal approach depending upon the
surgeon’s preference.
Rupture was defined as the presence of blood
outside the aorta and diagnosed with spiral computed
tomography imaging or at laparotomy. Symptomatic
patients were those with an intact AAA on CT
scanning and recent onset back, abdominal or groin
pain.
POSSUM scoring is an audit tool, which is used
to measure the pre-operative physiological state of
the patient and the severity of surgery performed.
Each patient receives two scores, a mean advanced
physiology score (APS) and an operative severity
score (OSS). The higher the score, the greater the
pre-operative physiological disturbance (in the case
of the APS) or severity of operation (in the case of
the OSS). The two groups of patients were
compared to see if there was a statistically
significant difference.
Data was analysed with the Mann–Whitney U-test
for independent samples, using SPSS 11.01 (SPSS Inc.,
Chicago. USA). A p-value of !0.05 was taken as the
threshold for statistical significance. Continuous vari-
ables are expressed as mean and standard deviation
(SD) throughout this paper.ResultsER group
Twenty-one patients (19 male, two female) with a
mean age of 73.7 years (SDG6.3) underwent ER (11
sAAA, 10 rAAA). Seven of these patients had been
seen in other hospitals in the region, found to be unfit
for open repair, and transferred to Leicester Royal
Infirmary (LRI) for consideration for endovascular
repair (rAAAZ4, sAAAZ3). The remaining 14
patients were admitted directly to the LRI via either
the Accident and Emergency Department or the Out
Patients Department. In total, 11 patients were deemed
unfit for open repair by a consultant anaesthetist who
assessed them prior to surgery (rAAAZ5, sAAAZ6).
The remaining patients were all deemed fit for open
repair. All patients underwent pre-operative spiral CT
scanning, which confirmed rupture in 10 patients. All
aneurysms were morphologically suitable for ER on
CT. All aneurysms were infrarenal. Three patients
had false aneurysms secondary to previous open
AAA repair (rAAAZ2, sAAAZ1); the rest were
degenerative aorto-iliac aneurysms. The median
duration of symptoms prior to hospitalisation was
3 days (range: 1 h–1 month). Symptoms suffered were
collapse and back pain (nZ1); collapse and abdominal
pain (nZ1); abdominal pain alone (nZ6); back pain
alone (nZ8); abdominal and back pain (nZ4); bilateral
groin pain (nZ1). Three patients were hypotensive
(systolic blood pressure !100 mmHg) on admission;
all three had a ruptured AAA. Four patients had their
operation under local anaesthesia and with sedation,
and a further three cases were performed with
regional anaesthesia alone. The remaining 14 cases
were performed using a general anaesthetic.
Four mono-iliac stent-grafts were used, and the
remainder were aorto-bi-iliac stents. Intra-operative
blood loss was recorded as ‘minimal’ or was not
recorded in all but three patients. In these cases blood
loss was recorded as 300, 500, and 1500 ml. Post-
operatively, 10 of the 21 patients went to the intensive
care unit (ITU), and nine were transferred to the high
dependency unit (HDU). Two patients spent 4 h in the
theatre recovery department before being transferred
back to the vascular ward. The mean amount of time
spent in critical care by all patients was 1.3 days
(range: 0–4 days), and the mean length of hospital stay
was 7 days (range 4–20).
The 30-day mortality was zero in the patients who
had sAAA and 11% (one patient) in the group of
patients with rAAA. This patient, who had undergone
conversion to open repair, died 12 h post-operativelyEur J Vasc Endovasc Surg Vol 31, April 2006
Table 1. Comparison of pre-operative, intra-operative and post-
operative results of ER and OR
ER (nZ21) OR (nZ22) p-value
Males (%) 90 91
Mean age (SD) 73.7 years (6.3) 71.8 years (5.7) 0.36
30-day mortality (%) 11 54 0.02
Mean time to theatre
(SD)
3.4 h (1.7) 5.0 h (4.3) 0.61
Mean operative time
(SD)
2.6 h (0.6) 3.1 h (0.9) 0.04
Mean blood
products (SD)
0.86 U (1.5) 10.7 U (8.9) !0.01
Mean time on critical
care unit (SD)
1.5 days (1.5) 6.1 days (7.5) 0.01
Mean hospital stay
(SD)
8.5 days (4.6) 17.5 days (15.
3)
0.02
Mean number
complications (SD)
0.8 (1.5) 1.1 (8.9) 0.28
Mean POSSUM APS 20.7 26.5 0.07
Mean POSSUM OSS 17.8 25.4 !0.01
Time to theatre, time from admission to LRI to start of anaesthetic
monitoring; blood products, packed red cells, platelets, fresh frozen
plasma or cryoprecipitate transfused intra-operatively; compli-
cations, total number of all complications; APS, advanced physi-
ology score; OSS, operative severity score.
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cerebro-vascular accident. Four patients developed a
type 1 endoleak, requiring five secondary endovas-
cular procedures. Other early and late complications
included respiratory tract infections (nZ2), angina
(nZ2), renal impairment which resolved without
the need for dialysis (nZ2), colonic ischaemia
necessitating bowel resection and stoma formation
(nZ1), wound infection which required debridement
in theatre (nZ1) and groin seromas (nZ2). The mean
number of all complications for this group was 0.8 (SD
1.5) complications per patient.
Follow-up investigations in this group included
clinical examination, ultra-sound scanning every 3
months, and CT scans every 6 months. Four patients
have been noted to have type 2 endoleaks in the
follow-up period.
The mean follow-up time was 32.3 months (7–106
months), and during this time, mortality for all (rAAA
and sAAA) patients in this study was 20% (four
patients). Two patients died at home at 10 and 11
months following operation, of unknown causes.
There was no information from post mortems
available to us. Neither of these patients had a
diagnosed endoleak at the time of death, and one of
them was known to be suffering from end-stage
myeloma at the time if his death. The other two
patients died at 8 and 25 months after surgery, of a
cerebro-vascular accident and lung carcinoma,
respectively.
Complete POSSUM data was only available on 14
patients in the ER group. The mean advanced
physiological score for these patients was 20.7, and
the mean operative severity score was 17.8. Numbers
are too small to allow an accurate mortality prediction.OR group
Twenty-two patients (20 male, two female) with a
mean age of 71.8 years (SDG5.7) underwent OR (11
sAAA, 10 rAAA) consecutively. Sixteen patients
underwent pre-operative CT scanning and six were
transferred directly to theatre. The 30-day mortality
was 54% (seven patients) for rAAA patients, and 9%
(one patient) for the sAAA patients. Complications
suffered by this group included respiratory failure
(nZ5), colonic ischaemia (nZ4), renal failure (nZ3),
cardiac arrhythmia (nZ3), sepsis (nZ2), lower respir-
atory tract infection (nZ2), myocardial infarction or
angina (nZ2), abdominal compartment syndrome
(nZ1), gastro-intestinal bleed (nZ1), wound infection
(nZ1), congestive cardiac failure (nZ1), and common
femoral artery embolus (nZ1). These 26 complicationsEur J Vasc Endovasc Surg Vol 31, April 2006occurred in 16 patients, with a mean number of
complications of 1.1 (SD 8.9) per patient.
Table 1 shows the results of comparison using the
Mann–Whitney U-test. There was no significant
difference between the ages or time from admission
to the surgery between the two groups. There were
statistically significant differences (p!0.05) between
the 30-day mortality of those patients with rAAA, the
length of surgery, amount of blood products trans-
fused, time spent on critical care and total time spent
in hospital.
There were statistically significant differences
between the advanced physiology and the operative
severity POSSUM scores of the two groups.Discussion
These data show that endovascular repair of ruptured
and symptomatic aortic aneurysms is technically
possible and is associated with reduction in mortality,
operation time, critical care stay, total hospital stay and
blood transfusion requirements. In addition, assess-
ment of suitability for ER with CT scanning does not
appear to significantly delay transfer to theatre. We
have previously investigated potential time delay
associated with CT scanning and the current findings
support our previous work.19
There was a significant difference between the
POSSUM operative severity scores in each group.
The operative severity score assesses, retrospectively,
the extent and severity of the surgery performed based
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significantly less disruptive operation than OR. There
was no significant difference between the POSSUM
advanced physiological scores of the two groups. The
physiological score is based on 14 variables, which
relate to the physiological condition of the patient and
are measured at the time of operation. The difference
between the two groups in this case implies that the
patients who underwent ER were no more physio-
logically stable than those who underwent OR, despite
the fact that 11 of the patients who underwent ER had
been thought to be unfit for OR by the consultant
anaesthetist treating them.
Of the patients who underwent OR, six did not have
a CT pre-operatively. These patients were too unstable
to tolerate a scan. The remaining patients did have pre-
operative CT scans, but as the correct personnel (i.e. a
consultant vascular surgeon and a consultant radiol-
ogist trained in endovascular techniques) were not
available on the day, morphological measurements of
the AAAwere not recorded.
There are several important points that have
become apparent during establishment of this pro-
gramme. There is a definite learning curve in terms of
immediate assessment of suitability for ER, urgent
transfer to theatre and rapid deployment of a stent-
graft device. Our experience builds upon our elective
programme of over 400 stent-grafts and participation
in the UK EVAR trial.
In addition, there are logistic problems of staff
availability out of hours (vascular surgeon, vascular
radiologist, trained radiology and theatre personnel)
and this may impact on the future development of
vascular surgical and radiological rotas, particularly if
this technique becomes more widely adopted or a
national trial is instituted.
In this case series, both bifurcated and aorto uni-
iliac systems have been used. We have learnt during
this time that using a bifurcated system in a stable
patient avoids the risk of crossover graft infection in
the groins, although there have been problems with
rapid cannulation of the contralateral limb in large
volume aneurysm sacs and unstable patients.
This study provides data on only a small number of
patients. The three main criteria that had to be met
before a patient could undergo emergency ER
(haemodynamic stability enough to allow for a CT
scan, morphological suitability for ER and availability
of the correct personnel) limited the number of
patients we were able to operate on. The small number
of patients in our study is a testament to this.
We use CT scanning to assess morphology of
aneurysms pre-operatively. Previous work from this
department has shown that CT scanning does notcause a significant delay in these patients,19 and
although we have no experience in the use of a marker
catheter angiogram in theatre (without CTassessment)
there are concerns that this might underestimate the
proximal neck morphology.20
The first publication relating to emergency ERwas a
case report from Nottingham, which appeared in the
literature in 1994.7 Since then, several centres in the
Europe and North America10–16 have reported on case
series of between 12 and 21 patients, with mortality
rates ranging from 9.5 to 45%. The wide ranging
results from the current evidence base reflects the fact
that ER for rAAA is still in its infancy and published
data is rare and consists of short case series and no
controlled trials. Our 30-day mortality rate of 11% is at
the lower end of the range of the published mortality.
This can be explained by the fact that we have
included patients who had symptomatic AAA’s and
urgent (as opposed to emergency) aneurysm repair,
and could in some part be due to the small number of
patients in this study. The only other publication with
a lower mortality rate13 consists of results of a case
series of patients who underwent ER under local
anaesthesia with intravenous sedation. A mortality
rate of 9.5% was achieved.
This study provides more evidence that ER is not
only feasible as an alternative to OR in the emergency
setting, but also that it may be preferable to open
surgery in suitable cases.
It is clear that future research should assess the
efficacy of ER in the emergency setting, although the
infrastructure is not yet in place for a randomised
controlled trial. Obtaining informed consent for such a
trial would also be very difficult in these patients, and
thorough assessment of this technique may only occur
if and when elective ER is accepted as a viable
procedure.Conclusion
There is a high mortality rate associated with ruptured
abdominal aortic aneurysm, and much room for
improvement in the management of these cases.
Endovascular techniques currently under scrutiny
appear to have drawbacks associated with long term
durability—including endoleaks, graft migration and
late rupture. It could, however, be argued that in cases
of symptomatic and ruptured aneurysms treatment
should focus on stabilising the patient with minimally
invasive surgery in the short term with a view to
definitive surgery on an elective basis if necessary. The
national EVAR trials are evaluating endovascular
repair in elective patients; but a similar randomisedEur J Vasc Endovasc Surg Vol 31, April 2006
S. Franks et al.350controlled trial would be very difficult to institute for
patients with ruptured aneurysms—and the small
number of cases which have been performed at
Leicester Royal Infirmary over a 6 year period is a
testament to that. However, this study has shown that
it is possible to repair aneurysms using endovascular
techniques on an urgent and emergent basis.References
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